Oct 26, 2023 / 10:00AM GMT
Presentation
Oct 26, 2023 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
Takeda Pharmaceutical Co Ltd
(FRA:TKD)
€
25.61
0.16 (0.63%)
Market Cap: 40.44 Bil
Enterprise Value: 65.50 Bil
PE Ratio: 23.27
PB Ratio: 0.97
GF Score: 82/100 Q2 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 26, 2023 / 10:00AM GMT
Release Date Price:
€25.7
(-5.17%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot